You are here

  • Home
  • Archive
  • Volume 79, Issue 9
  • IgG and plasma viscosity as markers of disease activity in primary Sjogren’s syndrome-related lymphocytic interstitial pneumonia

Article Text

Article menu
Download PDFPDF
Interstitial lung disease
IgG and plasma viscosity as markers of disease activity in primary Sjogren’s syndrome-related lymphocytic interstitial pneumonia
  1. Sughra Alawi1,
  2. Giles Dixon1,
  3. Nidhi Bhatt1,2,
  4. Huzaifa I Adamali1,
  5. Harsha Gunawardena1,3
  1. 1 Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK
  2. 2 Cellular Pathology, North Bristol NHS Trust, Bristol, UK
  3. 3 Department of Rheumatology, North Bristol NHS Trust, Bristol, UK
  1. Correspondence to Dr Giles Dixon, Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, BS10 5NB, UK; gilesdixon{at}nhs.net

https://doi.org/10.1136/thorax-2024-221495

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    A 33-year-old woman presented with an 8-month history of dry cough and progressive dyspnoea. Two months later, she developed dry eyes and mouth, petechial rash over both feet, left jaw pain and weight loss. She had no significant medical, medication, smoking or occupational history. Her father had Raynaud’s disease and paternal uncle had systemic lupus erythematosus.

    Her physical examination revealed oxygen saturations of 94%, mild painful swelling of the left parotid gland and a petechial rash over the feet. Respiratory examination revealed bilateral inspiratory crackles and squawks up to mid-zones.

    Routine blood investigations revealed normal full blood count, routine biochemistry and a raised plasma viscosity 2.43 mPa.s (1.50–1.72). Total serum protein was raised at 98 (60–80) g/L with a polyclonal response with elevated immunoglobulin IgG 59 g/L (6–16) and IgM 4.54 g/L (0.5–1.9) levels. There were no serum or urine monoclonal proteins. Autoantibody examination was positive for antinuclear antibody, subtyped as anti-Ro (SS-A) and anti-La (SS-B) antibodies. Rheumatoid factor was negative. Serum …

    View Full Text

    Footnotes

    • Contributors SA, GD, NB, HIA and HG contributed to the inception, writing and production of the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.